
Sign up to save your podcasts
Or


Based on Podcast App listening data
This week's biggest winners and losers in the stock market.
On this episode of Stock Movers, we look at some of the week's biggest gainers and decliners:
- US airline stocks, like United Airlines (UAL) and Southwest (LUV) slipped into a bear market as Wall Street warns that the war in the Middle East threatens to dramatically squeeze profits by driving up fuel costs. The S&P Supercomposite Airlines Industry Index closed down 4.1% on Friday afternoon, extending a skid into a sixth day. The group is down over 22% from a multi-year high marked just last month. A decline of 20% or more from a peak is defined as a bear market. The sharp decline in shares stems from the Iran conflict, which has caused the prices of jet fuel to surge.
- Cruise lines like Carnival (CCL) and Norwegian Cruise Line (NCLH) also saw shares fall this week on concerns over disruptions stemming from the conflict in the Middle East.
- ServiceNow (NOW) was among a few software stocks that saw gains this past week.
See omnystudio.com/listener for privacy information.
Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Carol Massar and Tim Stenovec.
- Marvell Technology (MRVL) shares jumped as much as 19% after the chipmaker delivered a bullish sales outlook, saying that data center demand was growing even faster than anticipated. Revenue will be as much as $2.52 billion in the fiscal first quarter, which runs through April, Marvell said in a statement Thursday. Analysts had estimated $2.28 billion on average.
- Boeing (BA) is closing in on one of the largest sales in its history, a 500-aircraft order for 737 Max jets set to be unveiled when President Donald Trump travels to Beijing for his first state visit to China since 2017, people familiar with the matter said. Boeing’s aircraft stand to feature prominently in a trade agreement between China President Xi Jinping and Trump, who has used the US planemaker as a tool to sweeten accords with other governments. Boeing shares jumped as much as 4% following Bloomberg’s report. The stock was the best performer on the 30-member Dow Jones Industrial Average index as of 2:30 p.m. Friday in New York.
- BlackRock (BLK) curbed withdrawals from one of its biggest private credit funds after client requests for redemptions spiked, the latest sign of investor anxiety about the $1.8 trillion private credit industry. The firm’s $26 billion HPS Corporate Lending Fund, one of the largest non-traded business development companies, said in a statement Friday that shareholders requested 9.3% of their shares, but management decided to cap the repurchases at 5%. While the total value of shares would have been about $1.2 billion, according to Bloomberg calculations, investors will get back about $620 million that the fund held at year-end. BlackRock shares fell as much as 8.3% on Friday, while the stocks of alternative asset managers including KKR & Co. and Ares Management Corp. also swooned, as they’re off to their worst start to a year in a decade.
See omnystudio.com/listener for privacy information.
Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Costco (COST) shares are up, erasing an earlier decline, after the club chain reported strong second-quarter results. While bears point out that paid membership growth rates slowed during the quarter, Morgan Stanley attributes the deceleration to fewer new warehouse openings. Costco’s premium valuation is also a point of contention, as it trades at about 47 times forward earnings, which is ahead of Walmart and well above peer BJ’s Wholesale. Shares are up 16% year-to-date while the S&P 500 Index has slid 1.1%.
- Gap (GAP) reported fourth-quarter sales and profit that came in slightly below expectations, as two of its apparel chains underperformed. Old Navy, the company’s biggest brand, and Athleta, its smallest, missed comparable-sales estimates, while Gap and Banana Republic beat. Shares of Gap fell as much as 11% on Friday. That erased the stock’s gain for the year and was the biggest intraday drop since May.
- Day One Biopharmaceuticals (DAWN) saw its shares leap as much as 66%, the most intraday since June 2022, after Servier agreed to acquire the biotech company for $21.50 per share in cash, representing a total equity value of approximately $2.5 billion. Servier agreed to pay $21.50 a share for Day One in a deal that’s expected to close in the second quarter, the companies said on Friday. That’s a 68% premium to Day One’s closing price on Thursday.
See omnystudio.com/listener for privacy information.
On this episode of Stock Movers:
- Gap (GAP) shares drop after the company reported fourth-quarter sales and profit that came in slightly below expectations, as two of its apparel chains underperformed. Old Navy and Athleta missed comparable-sales estimates, while Gap and Banana Republic beat.
- Nutex Health (NUTX) shares fall after trading before regular market hours. The company reported EPS and sales below estimates. The company attributed the lower-than-expected revenue to a one-time cumulative true-up of arbitration claims that arbitrators determined were ineligible under the independent dispute resolution process, according to a press release.
- Marvell (MRVL) shares up after the chipmaker said its year-over-year revenue growth rate will accelerate each quarter throughout fiscal 2027, a bullish target that shows soaring demand from data center-related applications.
See omnystudio.com/listener for privacy information.
On this episode of Stock Movers:
- Marvell (MRVL) shares are up after the chipmaker said its year-over-year revenue growth rate will accelerate each quarter throughout fiscal 2027, a bullish target that shows soaring demand from data center-related applications.
- Gap (GAP) shares drop after the company reported fourth-quarter sales and profit that came in slightly below expectations, as two of its apparel chains underperformed.
- Blue Owl (OWL) shares fall after news that it has a £36 million exposure to Century Capital Partners Ltd., a London-based property lender that filed for administration last month.
See omnystudio.com/listener for privacy information.
Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Gap (GAP) shares fall after Old Navy, the clothing retailer’s biggest brand, missed consensus expectations for same-store sales growth. Its forecast for 1Q gross margins was also weaker than analysts expected, as tariffs presented a 2 percentage-point headwind.
- Marvell Technology (MRVL) shares jumped after the chipmaker delivered a bullish sales outlook, saying that data center demand was growing even faster than anticipated.
- Nutex Health (NUTX) fell 30% in trading after company reported EPS and sales below estimates.
See omnystudio.com/listener for privacy information.
US employers unexpectedly cut jobs in February and the unemployment rate rose, raising doubts about the health of the labor market. Nonfarm payrolls decreased 92,000 last month after a strong start to the year, according to Bureau of Labor Statistics data out Friday. The unemployment rate climbed to 4.4%. The decline in payrolls partly reflected a decrease in health care employment due to strike activity.
Bloomberg Surveillance broke the numbers and got instant reaction from:
See omnystudio.com/listener for privacy information.
Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Rheinmetall rises as much as 2.3% as defense stocks climb amidst ongoing conflict in the Middle East.
- Lufthansa shares climb as much as 3.7% after Europe’s largest carrier reported strong results and said it sees “significant” improvement in earnings in 2026.
- ITV shares climb as much as 7.9%, the most since November, after Kepler Cheuvreux analyst Conor O’Shea raised his recommendation on the stock to buy from hold as he sees the weakness in advertising demand dissipating.
See omnystudio.com/listener for privacy information.
Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Rheinmetall rises as much as 2.3% as defense stocks climb amidst ongoing conflict in the Middle East.
- Lufthansa shares climb as much as 3.7% after Europe’s largest carrier reported strong results and said it sees “significant” improvement in earnings in 2026.
- Zealand Pharma shares plummeted Friday after their experimental obesity shot failed to meet industry expectations in a study, casting doubt on their prospects of competing in the fast-growing market. Tiwa Adebayo
See omnystudio.com/listener for privacy information.
Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Carol Massar and Tim Stenovec.
- Broadcom (AVGO)'s CEO Hock Tan said the company expects its AI chip sales to top $100 billion next year, marking major inroads into territory dominated by Nvidia. “We have line of sight” to reach this milestone in 2027, he said during a conference call with analysts Wednesday. “We have also secured the supply chain required to achieve this.” Broadcom shares rose as much as 4.2% on Thursday after trading got underway in New York.
- Sable Offshore (SOC) saw its shares trade higher on word the US is considering using the emergency powers of a Cold War-era law to ease permitting for it’s contested plans to drill oil off the coast of California. The 1950s Defense Production Act, which gives the president broad powers over domestic industry, is “absolutely” under deliberation to help Sable, US Interior Secretary Doug Burgum said Thursday in an interview. Shares rose 12% on the news and are up more than 60% this week as investors positioned ahead of a possible move by the Trump administration.
- Roche (RHHBY) and Zealand Pharma (ZEAL)'s experimental obesity shot helped patients lose as much as 10.7% in a study, failing to clear a high bar set by some Wall Street analysts. The experimental shot, petrelintide, delivered weight loss with side effects comparable to placebo, with fewer than 5% of patients dropping out of the trial, Roche and Zealand said. The results came after 42 weeks of treatment. Roche’s American depositary receipts fell as much as 7% after the results were posted Thursday.
See omnystudio.com/listener for privacy information.
From the publisher's feed
Listen for Short conversations on today's biggest winners and losers in the stock market.
Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.
Ranked by our users in the last 21 days

404 Listeners

1,163 Listeners

2,178 Listeners

1,972 Listeners

421 Listeners

1,036 Listeners

1,297 Listeners

61 Listeners

61 Listeners

154 Listeners

86 Listeners

85 Listeners

72 Listeners

8 Listeners

9 Listeners